Bio-Techne Corp (TECH)
71.28
+0.23
(+0.32%)
USD |
NASDAQ |
Nov 22, 16:00
71.28
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Enterprise Value: 11.44B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 11.44B |
| November 21, 2024 | 11.40B |
| November 20, 2024 | 11.03B |
| November 19, 2024 | 10.66B |
| November 18, 2024 | 10.74B |
| November 15, 2024 | 10.85B |
| November 14, 2024 | 11.64B |
| November 13, 2024 | 12.18B |
| November 12, 2024 | 11.94B |
| November 11, 2024 | 11.98B |
| November 08, 2024 | 12.18B |
| November 07, 2024 | 12.25B |
| November 06, 2024 | 12.16B |
| November 05, 2024 | 12.45B |
| November 04, 2024 | 12.17B |
| November 01, 2024 | 12.08B |
| October 31, 2024 | 11.83B |
| October 30, 2024 | 12.19B |
| October 29, 2024 | 11.35B |
| October 28, 2024 | 11.29B |
| October 25, 2024 | 11.02B |
| October 24, 2024 | 10.97B |
| October 23, 2024 | 11.13B |
| October 22, 2024 | 11.23B |
| October 21, 2024 | 11.29B |
| Date | Value |
|---|---|
| October 18, 2024 | 11.43B |
| October 17, 2024 | 11.26B |
| October 16, 2024 | 11.52B |
| October 15, 2024 | 11.80B |
| October 14, 2024 | 11.84B |
| October 11, 2024 | 11.77B |
| October 10, 2024 | 11.71B |
| October 09, 2024 | 11.91B |
| October 08, 2024 | 11.83B |
| October 07, 2024 | 11.79B |
| October 04, 2024 | 11.99B |
| October 03, 2024 | 11.87B |
| October 02, 2024 | 12.41B |
| October 01, 2024 | 12.53B |
| September 30, 2024 | 12.81B |
| September 27, 2024 | 12.65B |
| September 26, 2024 | 12.55B |
| September 25, 2024 | 12.06B |
| September 24, 2024 | 12.45B |
| September 23, 2024 | 12.42B |
| September 20, 2024 | 12.59B |
| September 19, 2024 | 12.91B |
| September 18, 2024 | 12.30B |
| September 17, 2024 | 12.11B |
| September 16, 2024 | 12.03B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.320B
Minimum
Mar 16 2020
21.26B
Maximum
Sep 24 2021
12.93B
Average
12.41B
Median
Nov 07 2022
Enterprise Value Benchmarks
| Bio-Rad Laboratories Inc | 8.899B |
| Boston Scientific Corp | 141.27B |
| ResMed Inc | 36.04B |
| Zimmer Biomet Holdings Inc | 27.95B |
| AIM ImmunoTech Inc | 8.915M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 33.60M |
| Revenue (Quarterly) | 289.46M |
| Total Expenses (Quarterly) | 249.47M |
| EPS Diluted (Quarterly) | 0.21 |
| Gross Profit Margin (Quarterly) | 63.23% |
| Profit Margin (Quarterly) | 11.61% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | 1.647 |